Market Expansion Procaps is actively expanding its presence across Latin America, with recent moves to relocate headquarters to Bogotá and securing substantial equity investments. This indicates a strategic focus on growing its regional footprint, providing opportunities for suppliers and partners in logistics, distribution, and regional regulatory consulting.

Innovative Product Pipeline Procaps is involved in advanced clinical trials and therapeutics, including collaborations with pharmaceutical companies like Zentalis, highlighting ongoing innovation in oncology treatments. This creates potential for research collaborations, contract manufacturing, and supply chain support for emerging therapies.

Financial Recovery Despite recent NASDAQ delisting due to financial reporting delays, Procaps continues to demonstrate significant revenue and recent capital infusion of $130 million. Opportunities exist for financial services, audit support, and strategic partnerships to strengthen governance and stabilize investor relations.

Regulatory & Compliance Needs Procaps faces ongoing regulatory reporting challenges but remains active in the clinical development of promising treatments for resistant ovarian cancer. This presents opportunities for compliance consulting, regulatory affairs outsourcing, and technology solutions to streamline reporting processes.

Strategic Leadership Recent changes in executive and board leadership, alongside restructuring efforts, signal a focus on governance and strategic growth. Business development efforts can target executive training, corporate governance solutions, and leadership consultancy to support Procaps's transformation journey.